Published in Eksp Klin Gastroenterol on January 01, 2011
Electric field effect in atomically thin carbon films. Science (2004) 45.10
Two-dimensional gas of massless Dirac fermions in graphene. Nature (2005) 22.35
Two-dimensional atomic crystals. Proc Natl Acad Sci U S A (2005) 13.93
Detection of individual gas molecules adsorbed on graphene. Nat Mater (2007) 8.00
Control of graphene's properties by reversible hydrogenation: evidence for graphane. Science (2009) 5.70
Field-effect tunneling transistor based on vertical graphene heterostructures. Science (2012) 4.54
Strong light-matter interactions in heterostructures of atomically thin films. Science (2013) 3.62
Biased bilayer graphene: semiconductor with a gap tunable by the electric field effect. Phys Rev Lett (2007) 3.06
Room-temperature quantum Hall effect in graphene. Science (2007) 2.71
Effect of a high-kappa environment on charge carrier mobility in graphene. Phys Rev Lett (2009) 1.85
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Giant nonlocality near the Dirac point in graphene. Science (2011) 1.57
Molecular doping of graphene. Nano Lett (2007) 1.46
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Interaction-driven spectrum reconstruction in bilayer graphene. Science (2011) 1.01
Chemical composition of lipophylic compounds from the body surface of unfed adult Ixodes persulcatus ticks (Acari: Ixodidae). Exp Appl Acarol (2000) 0.88
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Search for dilepton resonances in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.83
Search for new phenomena in tt events with large missing transverse momentum in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.82
Search for scalar bottom quark pair production with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.82
Observation of a new χ(b) state in radiative transitions to Υ(1S) and Υ(2S) at ATLAS. Phys Rev Lett (2012) 0.82
Electronic properties of a biased graphene bilayer. J Phys Condens Matter (2010) 0.82
Search for production of resonant states in the photon-jet mass distribution using pp collisions at √s=7 TeV collected by the ATLAS detector. Phys Rev Lett (2012) 0.81
Treatment of Helicobacter pylori positive duodenal ulcers. Lancet (1990) 0.80
Antioxidant status of rats receiving lycopene in different doses. Bull Exp Biol Med (2003) 0.79
[Gastroesophageal reflux disease and respiratory apparatus pathology: the evidence of interrelation and unsolved problems]. Vestn Ross Akad Med Nauk (2005) 0.78
Search for the Higgs boson in the H→WW(*)→ℓ(+)νℓ(-)ν decay channel in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.78
Gastric cancer screening in selected population of Moscow region: retrospective evaluation. Eur Radiol (1999) 0.77
[Helicobacter pylori, endocrine cells of the gastric mucosa, and their function in duodenal ulcer]. Arkh Patol (1996) 0.77
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures]. Eksp Klin Gastroenterol (2003) 0.77
[Quantitative characterization of antagonistic activity of lactobacilli]. Zh Mikrobiol Epidemiol Immunobiol (2004) 0.77
Effects of flavonoids on the resistance of microsomes to lipid peroxidation in vitro and ex vivo. Bull Exp Biol Med (2003) 0.76
Hydrogenase electrodes for fuel cells. Biochem Soc Trans (2005) 0.76
Search for pair production of a heavy up-type quark decaying to a W boson and a b quark in the lepton + jets channel with the ATLAS detector. Phys Rev Lett (2012) 0.76
[Influence of tableted green tea on index the antioxidant status patients with disease digestion organs]. Vopr Pitan (2008) 0.76
[Efficacy of using inulin fortified fermented milk products in patients with functional constipation]. Vopr Pitan (2009) 0.75
Search for pair production of a new b' quark that decays into a Z boson and a bottom quark with the ATLAS detector. Phys Rev Lett (2012) 0.75
Measurement of the W+ W- cross section in sqrt(s) = 7 TeV pp collisions with ATLAS. Phys Rev Lett (2011) 0.75
[Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST]. Eksp Klin Gastroenterol (2008) 0.75
[A complicated case of diagnosis of ileo-cecal tuberculosis]. Klin Med (Mosk) (2001) 0.75
[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75
[Nutritional status in patients after gastrectomy due to gastric cancer]. Vopr Pitan (2012) 0.75
[Elastography for determination of hepatic fibrosis severity: registration study in Russia]. Eksp Klin Gastroenterol (2008) 0.75
[Losek therapy of duodenal ulcer in contamination with different strains of Helicobacter pylori]. Klin Med (Mosk) (1999) 0.75
[A non-invasive method of evaluation of Helicobacter pylori urease activity: its perfection and introduction to clinical practice]. Vestn Ross Akad Med Nauk (2006) 0.75
[Dietotherapy of patients with anorexia nervosa and eating disorders in inpatient clinic]. Vopr Pitan (2011) 0.75
[Clinical efficacy of reamberin in drug-addicts with hepatic lesions]. Klin Med (Mosk) (2013) 0.75
[Effectiveness of lamivudine in the treatment of chronic HBeAg-negative viral hepatitis B: results of continuous therapy for 18 months]. Klin Med (Mosk) (2003) 0.75
[Contemporary dietotherapy of the irritable bowel syndrome]. Vopr Pitan (2013) 0.75
[Helicobacter pylori and its role in pathology]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.75
[Modified therapy of herpetic infection]. Klin Med (Mosk) (2011) 0.75
[Pharmacoeconomics in helicobacter pylori infection (lecture)]. Ter Arkh (2000) 0.75
[Project. Therapy of acid-dependent diseases. First Moscow Agreement, February 5, 2003]. Eksp Klin Gastroenterol (2003) 0.75
[Selection of the surgery method for patients with high "stomach ulcers"]. Eksp Klin Gastroenterol (2005) 0.75
[Evaluation of inclusion of specialized carbohydrate-protein product with vitamins and mineral substances in the diet therapy of gastrointestinal and osteopenia diseases]. Eksp Klin Gastroenterol (2009) 0.75
[Serological methods of diagnosis of Helicobacter pylori infections: recommendations and perspective of use]. Klin Lab Diagn (2000) 0.75
[New recommendations about treatment of chronic virus hepatitis of Asian-Pacific Association for Studying the Liver (APASL): what changed in 2008?]. Eksp Klin Gastroenterol (2008) 0.75
[Study composition of lactoflora of the large intestine in patients with food allergy and irritable bowel syndrome]. Vopr Pitan (2011) 0.75
[Heartburn prevalence analysis: national epidemiologic examination of adult urban population (ARIADNE)]. Eksp Klin Gastroenterol (2008) 0.75
[The diagnosis of stomach cancer: the status of the problem, the outlook for improvement and the clinico-morphological aspects]. Ter Arkh (1997) 0.75
[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]. Klin Med (Mosk) (2010) 0.75
[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Antibiot Khimioter (2010) 0.75
[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?]. Klin Med (Mosk) (2005) 0.75
[The efficacy of transient liver elastography overweight patients with chronic liver diseases]. Eksp Klin Gastroenterol (2010) 0.75
[Inhibition of herpes simplex virus type 1 reproduction by probiotic bacteria in vitro]. Vopr Virusol (2010) 0.75
[Optimal diagnosis and therapy of gastroesophageal reflux disease]. Ter Arkh (2004) 0.75
[Use in immunohistochemical studies of a method of restoration of antigenic specificity as affected by microwaves in tissue fixed with formalin and embedded in paraffin]. Arkh Patol (1999) 0.75
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. Ter Arkh (2003) 0.75
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes]. Eksp Klin Gastroenterol (2004) 0.75
[Clinical efficacy of reamberine in therapy for influenza]. Ter Arkh (2010) 0.75
[The role of gastroesophageal reflux in malignization of post-burn and peptic esophageal strictures]. Vestn Ross Akad Med Nauk (2005) 0.75
[Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors]. Eksp Klin Gastroenterol (2003) 0.75
[Functional activity of neutrophilic granulocytes in patients with relapsing herpes]. Biull Eksp Biol Med (1995) 0.75
[An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis]. Vopr Pitan (2014) 0.75
[Influence of specialized carbohydrate protein product enrich vitamins and minerals status of patients with gastrointestianals pathology and osteopenia]. Vopr Pitan (2009) 0.75
[GERD epidemiology: East and West]. Eksp Klin Gastroenterol (2004) 0.75
[Current possibilities of X-ray diagnosis of small intestine diseases using the agent Entero-view]. Vestn Rentgenol Radiol (2001) 0.75
[Class I histocompatibility antigens as markers of human susceptibility to influenza A viruses]. Vestn Ross Akad Med Nauk (1995) 0.75
[Chronic HBeAg-negative viral gepatitis B: treatment is essential and possible]. Eksp Klin Gastroenterol (2007) 0.75
[Clinical significance of food antigens blotting capacity by patients with irritable bowel syndrome]. Vopr Pitan (2010) 0.75
[Modern strategy in the treatment of chronic hepatitis B: progress and prospects]. Eksp Klin Gastroenterol (2007) 0.75
[Gastroesophageal reflux disease and Helicobacter pylori]. Klin Med (Mosk) (2000) 0.75
[The prevalence of heartburn in the elderly patients in urban outpatient clinics in Russia]. Eksp Klin Gastroenterol (2010) 0.75
[Esomeprasol and rabeprasol effects on esophageal acidification in patients with gastroesophageal reflux disease, intensively metabolizing inhibitors of proton pump]. Ter Arkh (2005) 0.75
[Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study]. Eksp Klin Gastroenterol (2003) 0.75
[Value of the high gastroesophageal reflux registration in the diagnosis of extraesophageal manifestations of GERD]. Eksp Klin Gastroenterol (2010) 0.75
[Campylobacter in stool of patients with irritable bowel syndrome]. Eksp Klin Gastroenterol (2010) 0.75
[Perspectives of prevention and treatment of herpes symplex with regular recurrence]. Ter Arkh (2011) 0.75
[How can you assess the risk level in patients taking a NSAID and choose and algorithm of risk management? Gastroenterologist's expert opinion]. Eksp Klin Gastroenterol (2006) 0.75
[Effectiveness of cultured milk foods, enriched by bifidus bacteria and Lactobacillus rhamnosis GG (ATCC 53103, LGG) in patients with slackening of motility function of intestines]. Vopr Pitan (2011) 0.75
[Isomeric specific analysis of hydroxyeicosatetraenoic acid in blood samples from obese patients with non-alcoholic and alcoholic steatohepatitis]. Vopr Pitan (2014) 0.75
[Maastricht-3-2005: The Florentine mosaic of contradictions and compromises]. Eksp Klin Gastroenterol (2006) 0.75
[Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease]. Eksp Klin Gastroenterol (2011) 0.75